These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6364487)

  • 21. Gene therapy for tolerance: high-level expression of donor major histocompatibility complex in the liver overcomes naive and memory alloresponses to skin grafts.
    Cunningham EC; Tay SS; Wang C; Rtshiladze M; Wang ZZ; McGuffog C; Cubitt J; McCaughan GW; Alexander IE; Bertolino P; Sharland AF; Bowen DG; Bishop GA
    Transplantation; 2013 Jan; 95(1):70-7. PubMed ID: 23263501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
    Isakov N; Bach FH
    J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active role of chimerism in transplantation tolerance induced by antilymphocyte serum, sirolimus, and bone-marrow-cell infusion.
    Kanamoto A; Monaco AP; Maki T
    Transplantation; 2004 Sep; 78(6):825-30. PubMed ID: 15385800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene.
    Sembeil R; Sanhadji K; Vivier G; Chargui J; Touraine JL
    Transpl Immunol; 2004; 13(1):1-8. PubMed ID: 15203122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of histocompatibility barriers in congenic strains of mice. III. Passive enhancement of skin allografts in X-irradiated hosts.
    Cantrell JL; Kaliss N; Hildemann WH
    Transplantation; 1975 Feb; 19(2):95-101. PubMed ID: 1091043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of splenectomy on specific unresponsiveness to skin allografts induced in ALS-treated, marrow-injected mice.
    Wood ML; Gottschalk R; Monaco AP
    Transplantation; 1980 Apr; 29(4):320-3. PubMed ID: 6445103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of tolerance across major barriers using a two-step method with genetic analysis of tolerance induction.
    Mayumi H; Good RA
    Immunobiology; 1989 Mar; 179(1):86-108. PubMed ID: 2659501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerance of skin allografts incompatible at the entire H-2 complex induced in adult mice by the post-transplant treatment.
    Chutná J; Holán V; Sládecek M; Hasek M
    Folia Biol (Praha); 1986; 32(2):154-8. PubMed ID: 3522287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Participation of class II alloantigens in in vivo regulation of K/D region disparate thyroid graft rejection in mice.
    Isakov N; Bach FH
    J Immunol; 1985 Jun; 134(6):3580-5. PubMed ID: 2859332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of MHC and non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue.
    Wang YC; Mayne A; Sell KW; Ahmed-Ansari A
    Transplantation; 1990 Aug; 50(2):313-24. PubMed ID: 2200176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bm1 cardiac grafts.
    Mohiuddin M; Ruggiero V; Shen Z; DiSesa VJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):310-3. PubMed ID: 8751496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential immune response of congenic mice to ultraviolet-treated major histocompatibility complex class II-incompatible skin grafts.
    Vermeer BJ; Santerse B; Van De Kerckhove BA; Schothorst AA; Claas FH
    Transplantation; 1988 Mar; 45(3):607-10. PubMed ID: 3126570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerogenic behavior of skin allografts from neonatal mice.
    Markees TG; De Fazio SR; Gozzo JJ
    Transplantation; 1994 Nov; 58(9):1008-14. PubMed ID: 7974727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of H-2 regions in overcoming tissue incompatibility.
    Holán V; Hasek M
    Immunogenetics; 1981 Mar; 12(5-6):465-72. PubMed ID: 7011954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of tolerance of the Ia antigen disparate skin allografts.
    Holán V; Hasek M; Chutná J; Holoubková I
    Folia Biol (Praha); 1982; 28(6):395-408. PubMed ID: 6761152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in the prolongation of skin graft survival by pretransplant blood injections in the model system of congenic lines of chickens.
    Vilhelmová M
    Folia Biol (Praha); 1987; 33(2):114-29. PubMed ID: 3297815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal pancreas allografts for reversal of diabetes in rats. II. Induction of life-term-specific unresponsiveness to pancreas allografts across nonmajor histocompatibility complex barriers.
    Mullen Y; Shintaku IP
    Transplantation; 1982 Jan; 33(1):3-11. PubMed ID: 7039021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressor cell induction in donor-specific transfused mouse heart recipients.
    Shelby J; Wakely E; Corry RJ
    Surgery; 1984 Aug; 96(2):296-301. PubMed ID: 6235611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.